Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
49 Leser
Artikel bewerten:
(0)

Peripheral Vascular Interventions Market Worth $3.4B by 2022

PUNE, India, June 20, 2016 /PRNewswire/ --

ReportsnReports.com adds MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts 2016 - 2022 research report to the healthcare and medical devices sections of its online business intelligence library. The global market for peripheral vascular interventions, including lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents, will rise from $2.1 billion in 2015 to $3.4 billion by 2022, according to this research

Complete report on the Peripheral Vascular Interventions market spread across 157 pages, talking about 9 major companies, their products and supported with 43 tables as well as 43 figures is now available at http://www.reportsnreports.com/reports/596250-medipoint-peripheral-vascular-interventions-global-analysis-and-market-forecasts.html .

The growth in peripheral vascular interventions market is set to occur at a compound annual growth rate of 6.8% and driven by an increased demand for minimally invasive endovascular procedures, greater availability of improved solutions for femoropopliteal artery revascularization, and the rising prevalence of peripheral artery disease (PAD). Prevalence of PAD is rising worldwide due to an increase in risk factors such as diabetes, hypertension, obesity, and tobacco use, resulting in a greater demand for minimally invasive treatments. An increasing number of physicians trained in endovascular techniques will help to address this.

Drug-eluting devices, including DEB and drug-eluting stents, are expected to significantly impact the treatment paradigm of PAD during the forecast period, particularly for complex femoropopliteal and infrapopliteal artery lesions where bare-metal stents and standard balloon angioplasty have not been as effective as long-term treatments. The development of more efficient drug delivery systems that maintain drug concentration in the vessel wall for longer periods of time will be a significant market opportunity moving forward, as this will improve long-term efficacy."

The current key players within the large and dynamic peripheral interventions market are Abbott Vascular, Boston Scientific, C.R. Bard, Cook Medical, Cordis, Medtronic, and W.L. Gore. Recent high-profile acquisitions, such as Medtronic's acquisition of Covidien and Cardinal Health's acquisition of Cordis, will significantly impact the competitive landscape moving forward. Companies such as Biotronik, B. Braun, Maquet, and Eurocor are also strong potential competitors which are poised for growth due to investment in innovative technologies within this space, including DEB and polytetrafluoroethylene (PTFE)-covered stents.

Order a copy of MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts 2016 - 2022 research report at http://www.reportsnreports.com/Purchase.aspx?name=596250 .

This report focuses on the global peripheral vascular interventions market in North America (Canada, Mexico, US), Europe (France, Germany, Italy, Spain, Russia, UK), Asia-Pacific (APAC) (Australia, China, India, Japan, South Korea), and South America (Brazil). This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different technologies.

Another and related research titled Peripheral Vascular Interventions - Current and Future Players provides up-to-date information and in-depth analysis on the key players that shape this market. This includes an analysis of company market shares, industry trends, and corporate strategy. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different types of devices. NOTE: *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading vascular surgeons, interventional cardiologists, and interventional radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information. Abbott Vascular, Biotronik, Boston Scientific, C.R. Bard, Cook Medical, Cordis (Cardinal Health), Medtronic, Terumo, W.L. Gore and Other Players have been discussed in this research available at http://www.reportsnreports.com/reports/596251-peripheral-vascular-interventions-current-and-future-players.html .

Explore more reports on healthcare market as well as medical devices segment at http://www.reportsnreports.com/market-research/medical-devices/ .

About Us:

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect With Us on:

Facebook: https://www.facebook.com/ReportsnReports/

LinkedIn: https://www.linkedin.com/company/reportsnreports

Twitter: https: //twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.